Omnicell, Inc. (NASDAQ:OMCL) Short Interest Up 34.8% in March

Omnicell, Inc. (NASDAQ:OMCL - Get Free Report) saw a large increase in short interest in the month of March. As of March 31st, there was short interest totalling 2,210,000 shares, an increase of 34.8% from the March 15th total of 1,640,000 shares. Approximately 4.9% of the shares of the company are short sold. Based on an average daily volume of 523,600 shares, the days-to-cover ratio is presently 4.2 days.

Omnicell Stock Performance

OMCL traded up $0.38 during mid-day trading on Thursday, reaching $31.07. 218,940 shares of the company traded hands, compared to its average volume of 524,820. The company has a quick ratio of 1.22, a current ratio of 1.37 and a debt-to-equity ratio of 0.13. Omnicell has a 52-week low of $25.12 and a 52-week high of $55.74. The stock has a market capitalization of $1.46 billion, a P/E ratio of 115.04, a P/E/G ratio of 7.53 and a beta of 0.78. The company's fifty day moving average price is $34.67 and its 200-day moving average price is $41.03.

Omnicell (NASDAQ:OMCL - Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.57 by ($0.12). Omnicell had a return on equity of 3.82% and a net margin of 1.13%. On average, sell-side analysts expect that Omnicell will post 1.09 EPS for the current year.

Analyst Ratings Changes

Several research firms have weighed in on OMCL. JPMorgan Chase & Co. lowered their price target on Omnicell from $44.00 to $36.00 and set a "neutral" rating on the stock in a report on Thursday, March 20th. StockNews.com raised shares of Omnicell from a "hold" rating to a "buy" rating in a research note on Tuesday, April 15th. Wells Fargo & Company decreased their target price on shares of Omnicell from $40.00 to $38.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 17th. Benchmark reaffirmed a "buy" rating and set a $62.00 price objective on shares of Omnicell in a research report on Tuesday, February 4th. Finally, Bank of America lowered their target price on shares of Omnicell from $54.00 to $46.00 and set a "neutral" rating for the company in a report on Monday, January 6th. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, Omnicell presently has a consensus rating of "Hold" and an average price target of $50.67.

Hedge Funds Weigh In On Omnicell

Several large investors have recently added to or reduced their stakes in OMCL. Smartleaf Asset Management LLC raised its holdings in Omnicell by 51.5% during the fourth quarter. Smartleaf Asset Management LLC now owns 803 shares of the company's stock valued at $35,000 after acquiring an additional 273 shares during the period. Johnson Financial Group Inc. bought a new stake in Omnicell during the 4th quarter valued at approximately $37,000. Van ECK Associates Corp lifted its holdings in Omnicell by 47.0% in the 4th quarter. Van ECK Associates Corp now owns 985 shares of the company's stock worth $44,000 after purchasing an additional 315 shares in the last quarter. Headlands Technologies LLC bought a new stake in shares of Omnicell during the fourth quarter valued at approximately $53,000. Finally, First Horizon Advisors Inc. lifted its holdings in shares of Omnicell by 36.3% in the fourth quarter. First Horizon Advisors Inc. now owns 1,333 shares of the company's stock worth $59,000 after buying an additional 355 shares in the last quarter. Hedge funds and other institutional investors own 97.70% of the company's stock.

About Omnicell

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.